BG63384B1 - Бензамиди за лечение на невродегенеративни смущения - Google Patents

Бензамиди за лечение на невродегенеративни смущения Download PDF

Info

Publication number
BG63384B1
BG63384B1 BG101929A BG10192997A BG63384B1 BG 63384 B1 BG63384 B1 BG 63384B1 BG 101929 A BG101929 A BG 101929A BG 10192997 A BG10192997 A BG 10192997A BG 63384 B1 BG63384 B1 BG 63384B1
Authority
BG
Bulgaria
Prior art keywords
butyl
tert
nitrobenzamide
neurodegenerative condition
disease
Prior art date
Application number
BG101929A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101929A (en
Inventor
William FLITTER
William Garland
Allan Wilcox
Richard PAYLOR
Original Assignee
Centaur Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Application filed by Centaur Pharmaceuticals, Inc. filed Critical Centaur Pharmaceuticals, Inc.
Publication of BG101929A publication Critical patent/BG101929A/xx
Publication of BG63384B1 publication Critical patent/BG63384B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG101929A 1995-04-03 1997-09-29 Бензамиди за лечение на невродегенеративни смущения BG63384B1 (bg)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
PCT/US1996/004538 WO1996031462A1 (en) 1995-04-03 1996-04-03 Benzamides for neurodegenerative disorder treatment

Publications (2)

Publication Number Publication Date
BG101929A BG101929A (en) 1998-04-30
BG63384B1 true BG63384B1 (bg) 2001-12-29

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101929A BG63384B1 (bg) 1995-04-03 1997-09-29 Бензамиди за лечение на невродегенеративни смущения

Country Status (39)

Country Link
EP (1) EP0819113B1 (zh)
JP (1) JP3479658B2 (zh)
KR (1) KR100429120B1 (zh)
CN (1) CN1073552C (zh)
AR (1) AR002978A1 (zh)
AT (1) ATE202552T1 (zh)
AU (1) AU721045B2 (zh)
BG (1) BG63384B1 (zh)
CA (1) CA2215166A1 (zh)
CO (1) CO4700431A1 (zh)
CZ (1) CZ295852B6 (zh)
DE (1) DE69613567T2 (zh)
DK (1) DK0819113T3 (zh)
DZ (1) DZ2012A1 (zh)
EA (1) EA002031B1 (zh)
EE (1) EE03437B1 (zh)
ES (1) ES2160240T3 (zh)
GR (1) GR3036466T3 (zh)
HK (1) HK1016964A1 (zh)
HR (1) HRP960156B1 (zh)
HU (1) HUP9801759A3 (zh)
IL (1) IL117629A (zh)
IS (1) IS1919B (zh)
MA (1) MA23837A1 (zh)
MX (1) MX9707596A (zh)
MY (1) MY121206A (zh)
NO (1) NO318441B1 (zh)
NZ (1) NZ306204A (zh)
PL (1) PL184121B1 (zh)
PT (1) PT819113E (zh)
RO (1) RO116190B1 (zh)
SA (1) SA96160739B1 (zh)
SI (1) SI0819113T1 (zh)
SK (1) SK282900B6 (zh)
TN (1) TNSN96051A1 (zh)
TR (1) TR199701114T1 (zh)
TW (1) TW381073B (zh)
WO (1) WO1996031462A1 (zh)
YU (1) YU21096A (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038684A1 (en) * 1996-04-17 1997-10-23 Centaur Pharmaceuticals, Inc. Benzamide treatment of dementia associated with aids virus (hiv-1) infection
ES2235368T3 (es) 1997-10-27 2005-07-01 Sumitomo Pharmaceuticals Company, Limited Derivados de amida para tratar alteraciones neurodegenerativas de la retina.
WO1999059582A1 (en) * 1998-05-19 1999-11-25 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
EP1079820A1 (en) * 1998-05-19 2001-03-07 Centaur Pharmaceuticals, Inc. Benzamide therapeutics for the treatment of inflammatory bowel disease
WO2000064430A1 (fr) * 1999-04-23 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Inhibiteurs de l'apoptose
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
JP5850321B2 (ja) * 2010-02-10 2016-02-03 公立大学法人横浜市立大学 神経選択的転写抑制因子ＮＲＳＦに特異的に結合するｍＳｉｎ３Ｂに結合する化合物の利用
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学（Cn） 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
CN1073552C (zh) 2001-10-24
SI0819113T1 (en) 2001-10-31
KR100429120B1 (ko) 2004-08-18
HUP9801759A2 (hu) 1998-12-28
JPH11501319A (ja) 1999-02-02
EP0819113B1 (en) 2001-06-27
JP3479658B2 (ja) 2003-12-15
HUP9801759A3 (en) 2001-06-28
HRP960156A2 (en) 1997-10-31
WO1996031462A1 (en) 1996-10-10
AU721045B2 (en) 2000-06-22
TW381073B (en) 2000-02-01
MA23837A1 (fr) 1996-12-31
HRP960156B1 (en) 2002-04-30
AU5440496A (en) 1996-10-23
ES2160240T3 (es) 2001-11-01
EP0819113A1 (en) 1998-01-21
PT819113E (pt) 2001-10-30
AR002978A1 (es) 1998-05-27
CN1182416A (zh) 1998-05-20
SK282900B6 (sk) 2003-01-09
EE03437B1 (et) 2001-06-15
DK0819113T3 (da) 2001-10-15
EA199700287A1 (ru) 1998-04-30
MY121206A (en) 2006-01-28
IL117629A0 (en) 1996-07-23
CZ295852B6 (cs) 2005-11-16
PL184121B1 (pl) 2002-09-30
SA96160739B1 (ar) 2005-10-15
CO4700431A1 (es) 1998-12-29
IS1919B (is) 2004-03-15
HK1016964A1 (en) 1999-11-12
DE69613567D1 (de) 2001-08-02
YU21096A (sh) 1999-03-04
EE9700235A (et) 1998-04-15
PL322625A1 (en) 1998-02-02
IL117629A (en) 2000-08-13
SK132597A3 (en) 1998-09-09
NZ306204A (en) 1999-01-28
GR3036466T3 (en) 2001-11-30
NO974569D0 (no) 1997-10-02
RO116190B1 (ro) 2000-11-30
DE69613567T2 (de) 2002-04-18
KR19980703562A (ko) 1998-11-05
EA002031B1 (ru) 2001-12-24
NO974569L (no) 1997-11-21
ATE202552T1 (de) 2001-07-15
IS4569A (is) 1997-09-25
MX9707596A (es) 1998-06-30
BG101929A (en) 1998-04-30
CA2215166A1 (en) 1996-10-10
DZ2012A1 (fr) 2002-07-21
CZ309897A3 (cs) 1998-12-16
TNSN96051A1 (fr) 2005-03-15
NO318441B1 (no) 2005-03-21
TR199701114T1 (xx) 1998-02-21

Similar Documents

Publication Publication Date Title
US20060100461A1 (en) Acetamidobenzamide compounds for neurodegenerative disorders
US5907061A (en) Nitro- and aminobenzamide compounds for neurodegenerative disorders
US5472983A (en) Benzamide-containing pharmaceutical compositions
BG63384B1 (bg) Бензамиди за лечение на невродегенеративни смущения
US6077870A (en) Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US6140369A (en) Benzamides for neurodegenerative disorder treatment
US5643965A (en) Aminobenzamide compounds for the treatment of neurodegenerative disorders
AU720578B2 (en) Benzamide treatment of dementia associated with AIDS virus (HIV-1) infection
MXPA98008661A (en) Benzamide treatment of associated dementia the infection for the virus of the acquired immunodeficiency syndrome (human immunodeficiency virus)